{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:09:18Z","timestamp":1791173358238,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T00:00:00Z","timestamp":1381881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Medical Research Council"},{"name":"NIHR Centre for Liver Research"},{"DOI":"10.13039\/100010269","name":"The Wellcome Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.antiviral.2013.10.006","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T13:20:50Z","timestamp":1382361650000},"page":"636-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Differential effect of p7 inhibitors on hepatitis C virus cell-to-cell transmission"],"prefix":"10.1016","volume":"100","author":[{"given":"L.W.","family":"Meredith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Zitzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"McKeating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.10.006_b0005","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.01592-10","article-title":"Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission","volume":"85","author":"Brimacombe","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.10.006_b0010","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1128\/JVI.01102-13","article-title":"Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission","volume":"87","author":"Catanese","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.10.006_b0015","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.clinthera.2012.08.009","article-title":"Boceprevir: a protease inhibitor for the treatment of hepatitis C","volume":"34","author":"Chang","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.antiviral.2013.10.006_b0020","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/S1386-6532(06)80341-0","article-title":"Alpha-glucosidase inhibitors prevent the assembly and induce a reduction of HCV infectivity","volume":"36","author":"Chapel","year":"2006","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2013.10.006_b0025","first-page":"198a","article-title":"Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles","volume":"44","author":"Chapel","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2013.10.006_b0030","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1099\/vir.0.81503-0","article-title":"Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles","volume":"87","author":"Chapel","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.10.006_b0035","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1572-0241.1999.01001.x","article-title":"A pilot study of rimantadine for patients with chronic hepatitis C unresponsive to interferon therapy","volume":"94","author":"Fong","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2013.10.006_b0040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1208953","article-title":"Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C","volume":"368","author":"Gane","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.10.006_b0045","doi-asserted-by":"crossref","first-page":"e1003355","DOI":"10.1371\/journal.ppat.1003355","article-title":"Hepatitis C virus p7 is critical for capsid assembly and envelopment","volume":"9","author":"Gentzsch","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.10.006_b0050","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.22555","article-title":"Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel","volume":"48","author":"Griffin","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2013.10.006_b0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/315175","article-title":"Amantadine and rimantadine have no direct inhibitory effects against hepatitis C viral protease, helicase, ATPase, polymerase, and internal ribosomal entry site-mediated translation","volume":"181","author":"Jubin","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.10.006_b0060","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.antiviral.2010.02.312","article-title":"A novel hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-alpha-2b and nucleoside analogues","volume":"86","author":"Luscombe","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.10.006_b0065","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.clinthera.2012.07.011","article-title":"Telaprevir: a hepatitis C NS3\/4A protease inhibitor","volume":"34","author":"Matthews","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.antiviral.2013.10.006_b0070","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jhep.2013.01.019","article-title":"Early infection events highlight the limited transmissibility of hepatitis C virus in vitro","volume":"58","author":"Meredith","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2013.10.006_b0075","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nature12283","article-title":"Unusual architecture of the p7 channel from hepatitis C virus","volume":"498","author":"OuYang","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.10.006_b0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/0-387-25515-X_2","article-title":"Long alkylchain iminosugars block the HCV p7 ion channel","volume":"564","author":"Pavlovic","year":"2005","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2013.10.006_b0085","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1073\/pnas.1031527100","article-title":"The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives","volume":"100","author":"Pavlovic","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.10.006_b0125","doi-asserted-by":"crossref","first-page":"11255","DOI":"10.1128\/JVI.01807-13","article-title":"The efficiency of E2-p7 processing modulates the production of infectious hepatitis C virus","volume":"87","author":"Shanmugam","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.10.006_b0095","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1371\/journal.ppat.0030103","article-title":"Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions","volume":"3","author":"Steinmann","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.10.006_b0100","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/hep.21686","article-title":"Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus","volume":"46","author":"Steinmann","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2013.10.006_b0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2007.05.001","article-title":"Inhibition of hepatitis C virus p7 membrane channels in a liposome-based assay system","volume":"76","author":"StGelais","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.10.006_b0110","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1099\/vir.0.027441-0","article-title":"The subcellular localization of the hepatitis C virus non-structural protein NS2 is regulated by an ion channel-independent function of the p7 protein","volume":"92","author":"Tedbury","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.10.006_b0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.21959","article-title":"Hepatitis C virus cell\u2013cell transmission in hepatoma cells in the presence of neutralizing antibodies","volume":"47","author":"Timpe","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2013.10.006_b0120","doi-asserted-by":"crossref","first-page":"e1001087","DOI":"10.1371\/journal.ppat.1001087","article-title":"Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production","volume":"6","author":"Wozniak","year":"2010","journal-title":"PLoS Pathog."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213002969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213002969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T11:39:18Z","timestamp":1589197158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213002969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0166354213002969"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.10.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential effect of p7 inhibitors on hepatitis C virus cell-to-cell transmission","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}